Harrow Health Stock Alpha and Beta Analysis

HROW Stock  USD 37.74  0.03  0.08%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Harrow Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Harrow Health over a specified time horizon. Remember, high Harrow Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Harrow Health's market risk premium analysis include:
Beta
1.57
Alpha
(0.23)
Risk
4.04
Sharpe Ratio
(0.05)
Expected Return
(0.20)
Please note that although Harrow Health alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Harrow Health did 0.23  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Harrow Health stock's relative risk over its benchmark. Harrow Health has a beta of 1.57  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harrow Health will likely underperform. At this time, Harrow Health's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 52.02 in 2024, despite the fact that Tangible Book Value Per Share is likely to grow to (2.68).

Enterprise Value

505.81 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Harrow Health Backtesting, Harrow Health Valuation, Harrow Health Correlation, Harrow Health Hype Analysis, Harrow Health Volatility, Harrow Health History and analyze Harrow Health Performance.
For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Harrow Health Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Harrow Health market risk premium is the additional return an investor will receive from holding Harrow Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Harrow Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Harrow Health's performance over market.
α-0.23   β1.57

Harrow Health expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Harrow Health's Buy-and-hold return. Our buy-and-hold chart shows how Harrow Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Harrow Health Market Price Analysis

Market price analysis indicators help investors to evaluate how Harrow Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harrow Health shares will generate the highest return on investment. By understating and applying Harrow Health stock market price indicators, traders can identify Harrow Health position entry and exit signals to maximize returns.

Harrow Health Return and Market Media

The median price of Harrow Health for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 is 45.14 with a coefficient of variation of 11.41. The daily time series for the period is distributed with a sample standard deviation of 5.26, arithmetic mean of 46.13, and mean deviation of 4.33. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Recent Price Trend in Harrow is Your Friend, Heres Why
10/22/2024
2
Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrows Branded Eyecare Products
11/07/2024
3
Harrow VEVYE And Its Impact On The DED Market - Seeking Alpha
11/11/2024
4
Harrow Announces Third Quarter 2024 Financial Results
11/13/2024
5
Tesla, Disney stir market cap stock movers on Thursday
11/14/2024
6
Harrow Health, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
7
Harrow Inc Shares Up 4.51 percent on Nov 20
11/20/2024
8
Harrows ImprimisRx Subsidiary Receives 34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
11/21/2024
9
Harrow Trading Down 4.9 percent Whats Next
12/03/2024
10
Disposition of 9602 shares by Boll Andrew R. of Harrow Health at 14.76 subject to Rule 16b-3
12/06/2024

About Harrow Health Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Harrow or other stocks. Alpha measures the amount that position in Harrow Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield6.32E-46.0E-4
Price To Sales Ratio2.812.67

Harrow Health Upcoming Company Events

As portrayed in its financial statements, the presentation of Harrow Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Harrow Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Harrow Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Harrow Health. Please utilize our Beneish M Score to check the likelihood of Harrow Health's management manipulating its earnings.
28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Harrow Health

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.